Epidemiological study of influenza B in Shanghai during the 2009-2014 seasons: Implications for influenza vaccination strategy

Clinical Microbiology and Infection

Volumn 21, Issue 7, 2015, Pages 694-700

  Zhao, B ^a,b   Qin, S ^a   Teng, Z ^b   Chen, J ^b   Yu, X ^b   Gao, Y ^b   Shen, J ^b   Cui, X ^b   Zeng, M ^c   Zhang, X ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Municipal Center for Disease Control and Prevention   (China)

^c CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Epidemiology; Influenza B; Lineage; School aged children; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ANTIGENICITY; ARTICLE; ASSAY; CHILD; DISEASE TRANSMISSION; DRUG INDUSTRY; EPIDEMIC; EPIDEMIOLOGICAL MONITORING; FLU LIKE SYNDROME; GENE SEQUENCE; GROUPS BY AGE; HAEMAGGLUTININ INHIBITION ASSAY; HUMAN; INCIDENCE; INFLUENZA A; INFLUENZA B; INFLUENZA VACCINATION; INFLUENZA VIRUS B; MEDICAL RECORD REVIEW; OUTPATIENT; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEASON; VIRUS ISOLATION; VIRUS STRAIN; AGE; CHINA; EPIDEMIOLOGY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; IMMUNOLOGY; INFANT; INFLUENZA B VIRUS; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PREVALENCE; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHINA; EPIDEMIOLOGIC STUDIES; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84930817835     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.03.009     Document Type: Article

References (22)

1. Wang H., Fu C., Li K., Lu J., Chen Y., Lu E., et al. Influenza associated mortality in Southern China, 2010-2012. Vaccine 2014, 32:973-978.
2. Feng L., Shay D.K., Jiang Y., Zhou H., Chen X., Zheng Y., et al. Influenza-associated mortality in temperate and subtropical Chinese cities, 2003-2008. Bull World Health Organ 2012, 90:279-288B.
3. McCullers J.A., Saito T., Iverson A.R. Multiple genotypes of influenza B virus circulated between 1979 and 2003. J Virol 2004, 78:12817-12828.
4. Rota P.A., Wallis T.R., Harmon M.W., Rota J.S., Kendal A.P., Nerome K. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 1990, 175:59-68.
5. DiazGranados C.A., Denis M., Plotkin S. Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. Vaccine 2012, 31:49-57.
6. Ambrose C.S., Levin M.J. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother 2012, 8:81-88.
7. Toback S.L., Levin M.J., Block S.L., Belshe R.B., Ambrose C.S., Falloon J. Quadrivalent Ann Arbor strain live-attenuated influenza vaccine. Expert Rev Vaccines 2012, 11:1293-1303.
8. Feng L., Mounts A.W., Feng Y., Luo Y., Yang P., Feng Z., et al. Seasonal influenza vaccine supply and target vaccinated population in China, 2004-2009. Vaccine 2010, 28:6778-6782.
9. Reed C., Meltzer M.I., Finelli L., Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine 2012, 30:1993-1998.
10. Paul Glezen W., Schmier J.K., Kuehn C.M., Ryan K.J., Oxford J. The Burden of influenza B: a structured literature review. Am J Public Health 2013, 103:e43-51.
11. Wu P., Goldstein E., Ho L.M., Yang L., Nishiura H., Wu J.T., et al. Excess mortality associated with influenza A and B virus in Hong Kong, 1998-2009. J Infect Dis 2012, 206:1862-1871.
12. Chiu S.C., Lin J.H., Wang H.C., Wu H.S., Chang H.W., Lin Y.C., et al. Molecular epidemiologic and clinical characteristics of influenza B-associated complications among hospitalized patients during an outbreak in Taiwan. Int J Infect Dis 2014, 23:94-100.
13. Yu H., Huang J., Huai Y., Guan X., Klena J., Liu S., et al. The substantial hospitalization burden of influenza in central China: surveillance for severe, acute respiratory infection, and influenza viruses, 2010-2012. Influenza Other Respir Viruses 2014, 8:53-65.
14. Olson D.R., Heffernan R.T., Paladini M., Kouty K., Weiss D., Mostashari F. Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Med 2007, 4:e247.
15. Chan P.K., Chan M.C., Cheung J.L., Lee N., Leng T.F., Yeung A.C., et al. Influenza B lineage circulation and hospitalization rates in a subtropical city, Hong Kong, 2000-2010. Clin Infect Dis 2013, 56:677-684.
16. Esposito S., Marchisio P., Principi N. The global state of influenza in children. Pediatr Infect Dis 2008, 27(11 Suppl.):S149-S153.
17. Esposito S., Tagliabue C., Tagliaferri L., Semino M., Longo M.R., Principi N. Preventing influenza in younger children. Clin Microbiol Infect 2012, 18(Suppl. 5):42-49.
18. Reichert T.A., Sugaya N., Fedson D.S., Glezen W.P., Simonsen L., Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001, 344:889-896.
19. King J.C., Lichenstein R., Cummings G.E., Magder L.S. Impact of influenza vaccination of schoolchildren on medical outcomes among all residents of Maryland. Vaccine 2010, 28:7737-7742.
20. Yu H., Alonso W.J., Feng L., Tan Y., Shu Y., Yang W., et al. Characterization of regional influenza seasonality patterns in China and implications for vaccination strategies: spatio-temporal modeling of surveillance data. PLoS Med 2013, 10:e1001552.
21. Loeb M., Russell M.L., Moss L., Fonseca K., Fox J., Earn D.J., et al. Effect of influenza vaccine of children on infection rates in Hutterite communities: a randomized trial. JAMA 2010, 303:943-950.
22. Medlock J., Galvani A.P. Optimizing influenza vaccine distribution. Science 2009, 325:1705-1708.